Drug injury litigation falls under the category of personal injury within tort law. There are hundreds if not thousands of medications that have been associated with adverse events and severe side effects, and mass tort litigation can be common depending on the severity of adverse events and the number of patients who were injured.
SGLT2 Inhibitors: Case Study
A class of Type 2 diabetes medications called Sodium Glucose Co-Transporter 2 inhibitors (SGLT2i drugs) have been associated with a severe infection that attacks genital tissue. The condition is called Fournier’s gangrene but is also known as genital gangrene, flesh-eating bacteria, necrotizing fasciitis of the perineal, perianal, or genital areas, and gangrene of the genitals.
The gangrene effects both male and female patients who are beginning treatment with an SGLT2 inhibitor. Fournier’s gangrene is a rare disorder that has been associated with the use of SGLT2i drugs like:
- Xigduo XR
These drugs work by increasing the amount of glucose that excreted from the body through urine output from the kidneys. Fournier’s gangrene develops and spreads quickly and is life-threatening if left untreated. Victims seek redress for medical costs and expenses, lost wages, physical pain, and suffering, loss of consortium, funeral expenses, and increased cost of living expenses.
Typical claimant criteria would include:
- Type 2 diabetic who was prescribed treatment with a brand name SGLT2 inhibitor drug, and;
- Diagnosed with Fournier’s gangrene or necrotizing fasciitis after 2013, (when the first SGLT2 hit the U.S. market), and;
- Required hospitalization for gangrene of the perineal, perianal, or genital areas; and/or
- Suffered amputation due to Fournier’s gangrene
- Claimant has not hired an attorney
Legal claims made by plaintiffs involved in SGLT2i gangrene litigation include:
- Failure to Warn
- Breach of Implied Warranty